GB0920896D0 - Improvements in cancer chemotherapy - Google Patents
Improvements in cancer chemotherapyInfo
- Publication number
- GB0920896D0 GB0920896D0 GB0920896A GB0920896A GB0920896D0 GB 0920896 D0 GB0920896 D0 GB 0920896D0 GB 0920896 A GB0920896 A GB 0920896A GB 0920896 A GB0920896 A GB 0920896A GB 0920896 D0 GB0920896 D0 GB 0920896D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer chemotherapy
- chemotherapy
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0920896A GB0920896D0 (en) | 2009-11-28 | 2009-11-28 | Improvements in cancer chemotherapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0920896A GB0920896D0 (en) | 2009-11-28 | 2009-11-28 | Improvements in cancer chemotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0920896D0 true GB0920896D0 (en) | 2010-01-13 |
Family
ID=41572864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0920896A Ceased GB0920896D0 (en) | 2009-11-28 | 2009-11-28 | Improvements in cancer chemotherapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0920896D0 (en) |
-
2009
- 2009-11-28 GB GB0920896A patent/GB0920896D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2382331A4 (en) | Cancer biomarkers | |
IL216719A0 (en) | Pure-peg-lipid conjugates | |
HK1166247A1 (en) | Luggage | |
IL212905A0 (en) | Individualized cancer dignosis | |
GB201016139D0 (en) | Cancer phosholipidome | |
HK1214177A1 (en) | Cancer peptide therapeutics | |
EP2399785A4 (en) | Slide arrangement | |
GB201004853D0 (en) | Slide member | |
ZA201201981B (en) | Cancer cell apoptosis | |
EP2401408A4 (en) | Ovarian cancer methylome | |
GB0918722D0 (en) | Anti cancer agent | |
GB201000471D0 (en) | Slide member | |
EP2635579A4 (en) | Synthetic lethality in cancer | |
EP2502627A4 (en) | Anti-cancer agent | |
GB201001080D0 (en) | Self-Weighing luggage | |
EP2406304A4 (en) | Gaba-linked anthracycline-lipid conjugates | |
GB0910751D0 (en) | Prostate cancer vaccine | |
EP2139908A4 (en) | Li-rnai involved li suppression in cancer immunotherapy | |
GB0920896D0 (en) | Improvements in cancer chemotherapy | |
GB0809287D0 (en) | Improvements in cancer chemotherapy | |
IL202151A0 (en) | Improvements in safes | |
GB0906023D0 (en) | Insulin-Nanoparticle conjugates | |
GB0818566D0 (en) | Improvements in the chemotherapy of cancer | |
GB0718539D0 (en) | Improvements in cancer chemotherapy | |
GB201004712D0 (en) | Improvements in the chemotherapy of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |